0 XP   0   0   0

Amgen Inc.










Financial Health of Amgen Inc.




Comparing to competitors in the Other industry




  Industry Rankings  


Amgen Inc.
Buy, Hold or Sell?

Should you buy, hold or sell Amgen Inc.?

I guess you are interested in Amgen Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Amgen Inc.

Let's start. I'm going to help you getting a better view of Amgen Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Amgen Inc. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Amgen Inc. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Amgen Inc.. The closing price on 2022-12-06 was €269.40 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Amgen Inc. Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Amgen Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Amgen Inc. earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Amgen Inc. to the Other industry mean.
  • A Net Profit Margin of 32.2% means that €0.32 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amgen Inc.:

  • The MRQ is 32.2%. The company is making a huge profit. +2
  • The TTM is 25.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ32.2%TTM25.9%+6.3%
TTM25.9%YOY21.9%+4.0%
TTM25.9%5Y27.7%-1.8%
5Y27.7%10Y27.7%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ32.2%8.2%+24.0%
TTM25.9%7.4%+18.5%
YOY21.9%7.3%+14.6%
5Y27.7%6.7%+21.0%
10Y27.7%6.6%+21.1%
1.1.2. Return on Assets

Shows how efficient Amgen Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Amgen Inc. to the Other industry mean.
  • 3.4% Return on Assets means that Amgen Inc. generated €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amgen Inc.:

  • The MRQ is 3.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.4%TTM2.8%+0.6%
TTM2.8%YOY2.2%+0.6%
TTM2.8%5Y2.8%+0.0%
5Y2.8%10Y2.8%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%1.0%+2.4%
TTM2.8%1.0%+1.8%
YOY2.2%0.9%+1.3%
5Y2.8%0.9%+1.9%
10Y2.8%0.9%+1.9%
1.1.3. Return on Equity

Shows how efficient Amgen Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Amgen Inc. to the Other industry mean.
  • 58.7% Return on Equity means Amgen Inc. generated €0.59 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amgen Inc.:

  • The MRQ is 58.7%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 75.6%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ58.7%TTM75.6%-17.0%
TTM75.6%YOY15.8%+59.8%
TTM75.6%5Y33.0%+42.7%
5Y33.0%10Y33.0%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ58.7%3.1%+55.6%
TTM75.6%2.9%+72.7%
YOY15.8%2.6%+13.2%
5Y33.0%2.4%+30.6%
10Y33.0%2.4%+30.6%

1.2. Operating Efficiency of Amgen Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Amgen Inc. is operating .

  • Measures how much profit Amgen Inc. makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Amgen Inc. to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amgen Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY11.6%-11.6%
TTM-5Y28.1%-28.1%
5Y28.1%10Y28.1%0.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY11.6%9.2%+2.4%
5Y28.1%8.5%+19.6%
10Y28.1%8.5%+19.6%
1.2.2. Operating Ratio

Measures how efficient Amgen Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are €0.84 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Amgen Inc.:

  • The MRQ is 0.839. The company is less efficient in keeping operating costs low.
  • The TTM is 0.875. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.839TTM0.875-0.037
TTM0.875YOY0.902-0.027
TTM0.8755Y0.852+0.023
5Y0.85210Y0.8520.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8391.218-0.379
TTM0.8751.189-0.314
YOY0.9021.203-0.301
5Y0.8521.289-0.437
10Y0.8521.314-0.462

1.3. Liquidity of Amgen Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Amgen Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.68 means the company has €1.68 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Amgen Inc.:

  • The MRQ is 1.679. The company is able to pay all its short-term debts. +1
  • The TTM is 1.560. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.679TTM1.560+0.119
TTM1.560YOY1.605-0.046
TTM1.5605Y1.913-0.353
5Y1.91310Y1.9130.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6791.491+0.188
TTM1.5601.465+0.095
YOY1.6051.475+0.130
5Y1.9131.299+0.614
10Y1.9131.286+0.627
1.3.2. Quick Ratio

Measures if Amgen Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Amgen Inc. to the Other industry mean.
  • A Quick Ratio of 0.51 means the company can pay off €0.51 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amgen Inc.:

  • The MRQ is 0.510. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.472. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.510TTM0.472+0.037
TTM0.472YOY0.561-0.089
TTM0.4725Y0.765-0.293
5Y0.76510Y0.7650.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5100.612-0.102
TTM0.4720.602-0.130
YOY0.5610.600-0.039
5Y0.7650.563+0.202
10Y0.7650.552+0.213

1.4. Solvency of Amgen Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Amgen Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Amgen Inc. to Other industry mean.
  • A Debt to Asset Ratio of 0.94 means that Amgen Inc. assets are financed with 94.3% credit (debt) and the remaining percentage (100% - 94.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Amgen Inc.:

  • The MRQ is 0.943. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.944. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.943TTM0.944-0.002
TTM0.944YOY0.859+0.085
TTM0.9445Y0.869+0.076
5Y0.86910Y0.8690.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9430.562+0.381
TTM0.9440.583+0.361
YOY0.8590.586+0.273
5Y0.8690.583+0.286
10Y0.8690.576+0.293
1.4.2. Debt to Equity Ratio

Measures if Amgen Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Amgen Inc. to the Other industry mean.
  • A Debt to Equity ratio of 1,643.8% means that company has €16.44 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amgen Inc.:

  • The MRQ is 16.438. The company is unable to pay all its debts with equity. -1
  • The TTM is 27.926. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ16.438TTM27.926-11.488
TTM27.926YOY6.137+21.789
TTM27.9265Y11.385+16.540
5Y11.38510Y11.3850.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ16.4381.244+15.194
TTM27.9261.337+26.589
YOY6.1371.370+4.767
5Y11.3851.439+9.946
10Y11.3851.455+9.930

2. Market Valuation of Amgen Inc.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Amgen Inc. generates.

  • Above 15 is considered overpriced but always compare Amgen Inc. to the Other industry mean.
  • A PE ratio of 60.33 means the investor is paying €60.33 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amgen Inc.:

  • The EOD is 70.390. Neutral. Compare to industry.
  • The MRQ is 60.330. Neutral. Compare to industry.
  • The TTM is 76.192. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD70.390MRQ60.330+10.059
MRQ60.330TTM76.192-15.862
TTM76.192YOY117.426-41.234
TTM76.1925Y70.121+6.071
5Y70.12110Y70.1210.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD70.39036.308+34.082
MRQ60.33038.458+21.872
TTM76.19244.588+31.604
YOY117.42648.072+69.354
5Y70.12140.090+30.031
10Y70.12141.443+28.678
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Amgen Inc..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Amgen Inc.:

  • The MRQ is 155.872. Seems overpriced? -1
  • The TTM is 533.260. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ155.872TTM533.260-377.388
TTM533.260YOY731.683-198.423
TTM533.2605Y-73.869+607.129
5Y-73.86910Y-73.8690.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ155.8720.154+155.718
TTM533.2600.050+533.210
YOY731.6830.186+731.497
5Y-73.8690.158-74.027
10Y-73.8690.155-74.024

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Amgen Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 35.39 means the investor is paying €35.39 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Amgen Inc.:

  • The EOD is 41.293. Seems overpriced? -1
  • The MRQ is 35.392. Seems overpriced? -1
  • The TTM is 60.373. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD41.293MRQ35.392+5.901
MRQ35.392TTM60.373-24.981
TTM60.373YOY13.458+46.915
TTM60.3735Y23.016+37.357
5Y23.01610Y23.0160.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD41.2931.411+39.882
MRQ35.3921.419+33.973
TTM60.3731.575+58.798
YOY13.4581.352+12.106
5Y23.0161.288+21.728
10Y23.0161.330+21.686
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Amgen Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.215-1.833+183%-1.010+146%0.544+307%0.544+307%
Book Value Growth--0.305-1.515+597%-0.131+143%-0.492+261%-0.492+261%
Book Value Per Share--6.5245.975+9%14.653-55%9.912-34%9.912-34%
Book Value Per Share Growth--0.340-1.313+487%-0.068+120%-0.366+208%-0.366+208%
Current Ratio--1.6791.560+8%1.605+5%1.913-12%1.913-12%
Debt To Asset Ratio--0.9430.9440%0.859+10%0.869+9%0.869+9%
Debt To Equity Ratio--16.43827.926-41%6.137+168%11.385+44%11.385+44%
Dividend Per Share--1.8541.830+1%1.647+13%1.657+12%1.657+12%
Dividend Per Share Growth--0.0030.022-88%0.023-89%0.025-89%0.025-89%
Eps--3.8273.012+27%2.335+64%2.221+72%2.221+72%
Eps Growth--0.3870.013+2796%-0.493+227%-0.062+116%-0.062+116%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.3220.259+24%0.219+47%0.277+16%0.277+16%
Operating Margin----0%0.116-100%0.281-100%0.281-100%
Operating Ratio--0.8390.875-4%0.902-7%0.852-2%0.852-2%
Pb Ratio41.293+14%35.39260.373-41%13.458+163%23.016+54%23.016+54%
Pe Ratio70.390+14%60.33076.192-21%117.426-49%70.121-14%70.121-14%
Peg Ratio--155.872533.260-71%731.683-79%-73.869+147%-73.869+147%
Price Per Share269.400+14%230.900220.925+5%196.655+17%200.167+15%200.167+15%
Price To Total Gains Ratio66.208+14%56.747-48.400+185%2279.802-98%770.096-93%770.096-93%
Profit Growth--35.477-5.357+115%-58.174+264%-20.399+157%-20.399+157%
Quick Ratio--0.5100.472+8%0.561-9%0.765-33%0.765-33%
Return On Assets--0.0340.028+20%0.022+52%0.028+21%0.028+21%
Return On Equity--0.5870.756-22%0.158+270%0.330+78%0.330+78%
Revenue Growth---0.041-0.054+32%-0.042+3%-0.038-6%-0.038-6%
Total Gains Per Share--4.069-0.004+100%0.638+538%2.201+85%2.201+85%
Total Gains Per Share Growth---0.112-0.415+271%-18.161+16138%-7.839+6908%-7.839+6908%
Usd Book Value--3654259262.1603423179631.840+7%8804784139.260-58%8151075537.152-55%8151075537.152-55%
Usd Book Value Change Per Share--2.326-1.925+183%-1.060+146%0.571+307%0.571+307%
Usd Book Value Per Share--6.8506.273+9%15.384-55%10.407-34%10.407-34%
Usd Dividend Per Share--1.9461.921+1%1.729+13%1.740+12%1.740+12%
Usd Eps--4.0183.162+27%2.452+64%2.332+72%2.332+72%
Usd Price Per Share282.843+14%242.422231.949+5%206.468+17%210.156+15%210.156+15%
Usd Profit--2143738734.9601709339040.300+25%1402733383.620+53%1729596020.880+24%1729596020.880+24%
Usd Revenue--6654293077.4406584769119.400+1%6443970600.060+3%6285432634.352+6%6285432634.352+6%
Usd Total Gains Per Share--4.272-0.004+100%0.670+538%2.310+85%2.310+85%
 EOD+2 -3MRQTTM+31 -3YOY+24 -115Y+21 -1410Y+21 -14

3.2. Fundamental Score

Let's check the fundamental score of Amgen Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1570.390
Price to Book Ratio (EOD)Between0-141.293
Net Profit Margin (MRQ)Greater than00.322
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.510
Current Ratio (MRQ)Greater than11.679
Debt to Asset Ratio (MRQ)Less than10.943
Debt to Equity Ratio (MRQ)Less than116.438
Return on Equity (MRQ)Greater than0.150.587
Return on Assets (MRQ)Greater than0.050.034
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Amgen Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose271.150
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets63,700,000
Total Liabilities60,047,000
Total Stockholder Equity3,653,000
 As reported
Total Liabilities 60,047,000
Total Stockholder Equity+ 3,653,000
Total Assets = 63,700,000

Assets

Total Assets63,700,000
Total Current Assets24,062,000
Long-term Assets24,062,000
Total Current Assets
Cash And Cash Equivalents 9,502,000
Short-term Investments 1,976,000
Net Receivables 5,326,000
Inventory 4,757,000
Other Current Assets 2,501,000
Total Current Assets  (as reported)24,062,000
Total Current Assets  (calculated)24,062,000
+/-0
Long-term Assets
Goodwill 14,845,000
Intangible Assets 13,266,000
Long-term Assets Other 6,339,000
Long-term Assets  (as reported)39,638,000
Long-term Assets  (calculated)34,450,000
+/- 5,188,000

Liabilities & Shareholders' Equity

Total Current Liabilities14,331,000
Long-term Liabilities45,716,000
Total Stockholder Equity3,653,000
Total Current Liabilities
Short Long Term Debt 1,543,000
Accounts payable 1,204,000
Total Current Liabilities  (as reported)14,331,000
Total Current Liabilities  (calculated)2,747,000
+/- 11,584,000
Long-term Liabilities
Long term Debt 37,161,000
Long-term Liabilities Other 2,875,000
Long-term Liabilities  (as reported)45,716,000
Long-term Liabilities  (calculated)40,036,000
+/- 5,680,000
Total Stockholder Equity
Total Stockholder Equity (as reported)3,653,000
Total Stockholder Equity (calculated)0
+/- 3,653,000
Other
Capital Stock32,371,000
Common Stock Shares Outstanding 533,500
Net Debt 29,202,000
Net Invested Capital 42,357,000
Net Working Capital 9,731,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
63,997,000
59,373,000
59,535,000
59,707,000
61,669,000
65,011,000
64,637,000
62,948,000
62,539,000
59,773,000
64,993,000
61,165,000
59,196,000
59,294,000
63,700,000
63,700,00059,294,00059,196,00061,165,00064,993,00059,773,00062,539,00062,948,00064,637,00065,011,00061,669,00059,707,00059,535,00059,373,00063,997,000
   > Total Current Assets 
35,151,000
30,746,000
31,051,000
18,440,000
18,813,000
22,895,000
22,661,000
21,144,000
21,299,000
19,099,000
24,380,000
19,385,000
18,520,000
19,322,000
24,062,000
24,062,00019,322,00018,520,00019,385,00024,380,00019,099,00021,299,00021,144,00022,661,00022,895,00018,813,00018,440,00031,051,00030,746,00035,151,000
       Cash And Cash Equivalents 
7,358,000
5,525,000
11,415,000
6,037,000
7,687,000
9,145,000
9,087,000
6,266,000
6,112,000
6,630,000
11,969,000
7,989,000
6,528,000
5,203,000
9,502,000
9,502,0005,203,0006,528,0007,989,00011,969,0006,630,0006,112,0006,266,0009,087,0009,145,0007,687,0006,037,00011,415,0005,525,0007,358,000
       Short-term Investments 
18,943,000
16,233,000
9,438,000
2,874,000
325,000
2,276,000
3,273,000
4,381,000
4,454,000
1,452,000
952,000
48,000
16,000
1,980,000
1,976,000
1,976,0001,980,00016,00048,000952,0001,452,0004,454,0004,381,0003,273,0002,276,000325,0002,874,0009,438,00016,233,00018,943,000
       Net Receivables 
3,771,000
3,801,000
3,606,000
4,057,000
5,009,000
5,366,000
4,094,000
4,525,000
4,423,000
4,479,000
4,765,000
4,895,000
5,077,000
5,327,000
5,326,000
5,326,0005,327,0005,077,0004,895,0004,765,0004,479,0004,423,0004,525,0004,094,0005,366,0005,009,0004,057,0003,606,0003,801,0003,771,000
       Inventory 
3,016,000
3,176,000
3,243,000
3,584,000
3,682,000
3,840,000
3,942,000
3,893,000
4,017,000
4,115,000
4,152,000
4,086,000
4,411,000
4,554,000
4,757,000
4,757,0004,554,0004,411,0004,086,0004,152,0004,115,0004,017,0003,893,0003,942,0003,840,0003,682,0003,584,0003,243,0003,176,0003,016,000
       Other Current Assets 
2,063,000
2,011,000
3,349,000
1,888,000
2,110,000
2,268,000
2,265,000
2,079,000
2,293,000
2,423,000
2,542,000
2,367,000
2,488,000
2,258,000
2,501,000
2,501,0002,258,0002,488,0002,367,0002,542,0002,423,0002,293,0002,079,0002,265,0002,268,0002,110,0001,888,0003,349,0002,011,0002,063,000
   > Long-term Assets 
28,846,000
28,627,000
28,484,000
41,267,000
42,856,000
42,116,000
41,976,000
41,804,000
41,240,000
40,674,000
40,613,000
41,780,000
40,676,000
39,972,000
39,638,000
39,638,00039,972,00040,676,00041,780,00040,613,00040,674,00041,240,00041,804,00041,976,00042,116,00042,856,00041,267,00028,484,00028,627,00028,846,000
       Goodwill 
14,692,000
14,689,000
14,705,000
14,703,000
14,683,000
14,678,000
14,674,000
14,689,000
14,673,000
14,676,000
14,665,000
14,890,000
14,897,000
14,865,000
14,845,000
14,845,00014,865,00014,897,00014,890,00014,665,00014,676,00014,673,00014,689,00014,674,00014,678,00014,683,00014,703,00014,705,00014,689,00014,692,000
       Intangible Assets 
7,124,000
6,813,000
6,702,000
19,413,000
18,653,000
17,948,000
17,254,000
16,587,000
15,947,000
15,308,000
14,659,000
15,182,000
14,567,000
13,927,000
13,266,000
13,266,00013,927,00014,567,00015,182,00014,659,00015,308,00015,947,00016,587,00017,254,00017,948,00018,653,00019,413,0006,702,0006,813,0007,124,000
       Long-term Assets Other 
2,138,000
2,243,000
2,176,000
2,223,000
4,641,000
4,647,000
5,232,000
5,639,000
5,765,000
5,784,000
6,307,000
6,524,000
6,070,000
6,022,000
6,339,000
6,339,0006,022,0006,070,0006,524,0006,307,0005,784,0005,765,0005,639,0005,232,0004,647,0004,641,0002,223,0002,176,0002,243,0002,138,000
> Total Liabilities 
53,165,000
48,579,000
48,608,000
50,034,000
52,184,000
54,352,000
53,678,000
53,539,000
53,205,000
51,526,000
56,776,000
54,465,000
58,280,000
56,875,000
60,047,000
60,047,00056,875,00058,280,00054,465,00056,776,00051,526,00053,205,00053,539,00053,678,00054,352,00052,184,00050,034,00048,608,00048,579,00053,165,000
   > Total Current Liabilities 
12,706,000
10,622,000
10,737,000
12,835,000
11,827,000
10,523,000
9,953,000
11,653,000
12,869,000
14,585,000
14,842,000
12,184,000
12,886,000
12,618,000
14,331,000
14,331,00012,618,00012,886,00012,184,00014,842,00014,585,00012,869,00011,653,0009,953,00010,523,00011,827,00012,835,00010,737,00010,622,00012,706,000
       Short-term Debt 
3,705,000
2,816,000
2,049,000
2,953,000
0
0
0
0
0
0
0
0
0
0
0
000000000002,953,0002,049,0002,816,0003,705,000
       Short Long Term Debt 
3,705,000
2,816,000
2,049,000
2,953,000
1,840,000
91,000
91,000
91,000
1,556,000
4,324,000
4,288,000
87,000
844,000
817,000
1,543,000
1,543,000817,000844,00087,0004,288,0004,324,0001,556,00091,00091,00091,0001,840,0002,953,0002,049,0002,816,0003,705,000
       Accounts payable 
1,091,000
1,001,000
1,005,000
1,371,000
1,338,000
1,150,000
1,161,000
1,421,000
1,396,000
1,277,000
1,171,000
1,366,000
1,403,000
1,256,000
1,204,000
1,204,0001,256,0001,403,0001,366,0001,171,0001,277,0001,396,0001,421,0001,161,0001,150,0001,338,0001,371,0001,005,0001,001,0001,091,000
   > Long-term Liabilities 
40,459,000
37,957,000
37,871,000
37,199,000
40,357,000
43,829,000
43,725,000
41,886,000
40,336,000
36,941,000
41,934,000
42,281,000
45,394,000
44,257,000
45,716,000
45,716,00044,257,00045,394,00042,281,00041,934,00036,941,00040,336,00041,886,00043,725,00043,829,00040,357,00037,199,00037,871,00037,957,00040,459,000
       Long term Debt 
29,319,000
27,798,000
27,742,000
26,950,000
30,008,000
34,133,000
34,196,000
32,895,000
31,129,000
28,458,000
33,291,000
33,222,000
36,010,000
35,705,000
37,161,000
37,161,00035,705,00036,010,00033,222,00033,291,00028,458,00031,129,00032,895,00034,196,00034,133,00030,008,00026,950,00027,742,00027,798,00029,319,000
       Long-term Liabilities Other 
1,460,000
1,535,000
1,543,000
1,606,000
1,811,000
1,881,000
1,759,000
2,023,000
2,170,000
2,055,000
2,160,000
2,465,000
2,732,000
2,949,000
2,875,000
2,875,0002,949,0002,732,0002,465,0002,160,0002,055,0002,170,0002,023,0001,759,0001,881,0001,811,0001,606,0001,543,0001,535,0001,460,000
> Total Stockholder Equity
10,832,000
10,794,000
10,927,000
9,673,000
9,485,000
10,659,000
10,959,000
9,409,000
9,334,000
8,247,000
8,217,000
6,700,000
916,000
2,419,000
3,653,000
3,653,0002,419,000916,0006,700,0008,217,0008,247,0009,334,0009,409,00010,959,00010,659,0009,485,0009,673,00010,927,00010,794,00010,832,000
   Common Stock000000000000000
   Retained Earnings Total Equity000000000000000
   Accumulated Other Comprehensive Income 000000000000000
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue25,979,000
Cost of Revenue-6,454,000
Gross Profit19,525,00019,525,000
 
Operating Income (+$)
Gross Profit19,525,000
Operating Expense-16,835,000
Operating Income9,144,0002,690,000
 
Operating Expense (+$)
Research Development4,819,000
Selling General Administrative5,368,000
Selling And Marketing Expenses-
Operating Expense16,835,00010,187,000
 
Net Interest Income (+$)
Interest Income-
Interest Expense-1,197,000
Net Interest Income-1,197,000-1,197,000
 
Pretax Income (+$)
Operating Income9,144,000
Net Interest Income-1,197,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)6,701,00010,390,000
EBIT - interestExpense = -1,197,000
5,893,000
7,090,000
Interest Expense1,197,000
Earnings Before Interest and Taxes (ebit)-7,898,000
Earnings Before Interest and Taxes (ebitda)11,296,000
 
After tax Income (+$)
Income Before Tax6,701,000
Tax Provision-808,000
Net Income From Continuing Ops5,893,0005,893,000
Net Income5,893,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,246,0001,197,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SAMS.PA
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SAMS.PA.

SAMS.PA Daily Candlestick Chart
QDT.PA
9 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of QDT.PA.

QDT.PA Daily Candlestick Chart
OD7W.F
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OD7W.F.

OD7W.F Daily Candlestick Chart
ODET.PA
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ODET.PA.

ODET.PA Daily Candlestick Chart
NAVYA.PA
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NAVYA.PA.

NAVYA.PA Daily Candlestick Chart
MKEA.PA
20 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MKEA.PA.

MKEA.PA Daily Candlestick Chart
LYXF.F
23 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LYXF.F.

LYXF.F Daily Candlestick Chart
LVE.PA
25 minutes ago

I found you a Golden Cross on the daily chart of LVE.PA.

LVE.PA Daily Candlestick Chart
LVC.PA
25 minutes ago

I found you a Golden Cross on the daily chart of LVC.PA.

LVC.PA Daily Candlestick Chart
LDCE.F
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LDCE.F.

LDCE.F Daily Candlestick Chart
IS3U.F
27 minutes ago

I found you a Golden Cross on the daily chart of IS3U.F.

IS3U.F Daily Candlestick Chart
IMI.LSE
31 minutes ago

I found you a Golden Cross on the daily chart of IMI.LSE.

IMI.LSE Daily Candlestick Chart
EUN5.F
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EUN5.F.

EUN5.F Daily Candlestick Chart
EXV9.F
43 minutes ago

I found you a Golden Cross on the daily chart of EXV9.F.

EXV9.F Daily Candlestick Chart
EXHC.F
44 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of EXHC.F.

EXHC.F Daily Candlestick Chart
EUNS.F
44 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EUNS.F.

EUNS.F Daily Candlestick Chart
CAREERP.NSE
47 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CAREERP.NSE.

CAREERP.NSE Daily Candlestick Chart
SMSMED.CO
51 minutes ago

I found you a Bearish Engulfing Candle Pattern on the daily chart of SMSMED.CO.

SMSMED.CO Daily Candlestick Chart
PTG.WAR
56 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PTG.WAR.

PTG.WAR Daily Candlestick Chart
MTHH.CO
1 hour ago

I found you a Golden Cross on the daily chart of MTHH.CO.

MTHH.CO Daily Candlestick Chart
IPO.WAR
1 hour ago

I found you a Golden Cross on the daily chart of IPO.WAR.

IPO.WAR Daily Candlestick Chart
FLS.CO
1 hour ago

I found you a Golden Cross on the daily chart of FLS.CO.

FLS.CO Daily Candlestick Chart
EUR.WAR
1 hour ago

I found you a Evening Star Candle Pattern on the daily chart of EUR.WAR.

EUR.WAR Daily Candlestick Chart
ENT.WAR
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ENT.WAR.

ENT.WAR Daily Candlestick Chart
BRA.WAR
1 hour ago

I found you a Golden Cross on the daily chart of BRA.WAR.

BRA.WAR Daily Candlestick Chart